GPR17 and demyelinating disease: Together these findings suggest that GPR17 downregulation in differentiating OLs induces changes of both energy metabolism and membrane lipids required for their differentiation into mature myelinating cells, and that GPR17 targeting can be exploited to rescue metabolic dysfunctions typically associated to demyelinating diseases.